(MedPage Today) — The Centers for Medicare & Medicaid Services (CMS) announced a new experimental model late… Read More
June 2025
(MedPage Today) — Use of Janus kinase (JAK) inhibitors for rheumatoid arthritis (RA) was associated with significantly… Read More
A 63-year-old woman was evaluated for dyspnea and edema. Soft-tissue thickening was noted in the retroperitoneum and… Read More
TNF inhibitors have transformed outcomes for many, but not all, people with rheumatoid arthritis. Their approval in… Read More
Purpose to review Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in children, characterized… Read More
Polymyalgia rheumatica has long been neglected, especially when it comes to pharmaceutical development: but why? In 2025,… Read More
In adults with myasthenia gravis, treatment with intravenous inebilizumab, a CD19-specific monoclonal antibody, significantly improved function and… Read More
Intracranial aneurysms are common, and the risk of rupture is influenced by size, location, morphology, and factors… Read More
Myasthenia gravis, an immune-mediated neurologic disorder, has for the past century been treated effectively with various immunotherapies,… Read More
The field of pulmonary fibrosis has come a long way in the past 25 years, with the… Read More